Dyne Therapeutics Inc (DYN)

14.20 -0.22  -1.53% NASDAQ Oct 20, 16:00 14.20 0.00  0.00% After-Hours: 16:43 USD

Dyne Therapeutics Shareholders Equity (Quarterly):

452.60M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Shareholders Equity (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Shareholders Equity (Quarterly) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 452.60M
March 31, 2021 478.26M
Dec. 31, 2020 342.37M
Sept. 30, 2020 366.84M
June 30, 2020 132.48M
Dec. 31, 2019 14.04M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Benchmarks

Veracyte Inc 971.18M
Moderna Inc 6.704B
BridgeBio Pharma Inc -464.29M

Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum 14.04M Dec 2019
Maximum 478.26M Mar 2021
Average 297.76M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 467.15M
Total Liabilities (Quarterly) 14.55M


Dyne Therapeutics EPS beats by $0.10
SA Breaking News 05/06 08:10 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.